Director James C. Momtazee filed a Form 4 with the SEC on October 27, 2026, disclosing two transactions in Roivant Sciences Ltd. common shares dated October 23, 2026, related to the company's Non-Employee Director Compensation Plan.

Key Highlights

  • Award received: James C. Momtazee acquired 383 common shares on October 23, 2026, at a price of $0, pursuant to the Roivant Sciences Ltd. Non-Employee Director Compensation Plan, fully vested as of the grant date.
  • Tax withholding settlement: 77 common shares were disposed of on October 23, 2026, at $36.49 per share via net settlement to satisfy applicable tax withholding obligations.
  • Resulting ownership: Following both transactions, Momtazee directly beneficially owned 112,265 common shares.
  • Issuer and exchange: The issuer is Roivant Sciences Ltd., listed as NASDAQ:ROIV.
  • Filer role: Momtazee is identified in the filing as a Director of Roivant Sciences Ltd.

Momtazee Director Share Award and Net Settlement at Roivant Sciences

According to the Form 4 filed on October 27, 2026, director James C. Momtazee reported two transactions in Roivant Sciences Ltd. (NASDAQ:ROIV) common shares, both dated October 23, 2026. The first transaction was an acquisition of 383 common shares under transaction code "A," at a stated price of $0. The filing explains that this reflects an award of common shares received pursuant to the issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

The second transaction was a disposition of 77 common shares under transaction code "F," at a price of $36.49 per share. The filing describes this as a "net settlement" by the issuer of common shares previously granted to Momtazee pursuant to the Non-Employee Director Compensation Plan, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of those shares.

Following both reported transactions, Momtazee held 112,265 common shares directly. The Form 4 was signed by Sam Kaplan as attorney-in-fact for James C. Momtazee and dated October 27, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing discloses a director share award of 383 common shares at $0 and a net-settlement disposition of 77 shares at $36.49 on October 23, 2026, both under Roivant's Non-Employee Director Compensation Plan, leaving Momtazee with direct ownership of 112,265 common shares.